Cancer BiologyCancer CellPeer-reviewed
A CXCR4 partial agonist improves immunotherapy by targeting polymorphonuclear myeloid-derived suppressor cells and cancer-driven granulopoiesis
Jin Qian, Chenkai Ma, Quin T. Waterbury…·Timothy Cragin Wang
This paper shows that a CXCR4 partial agonist enhances immunotherapy in gastric cancer by targeting PMN-MDSCs and granulopoiesis.